Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

NCT03562897 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Ovarian Neoplasm
Endocrine Gland Neoplasm
Urogenital Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Female Urogenital Diseases
Female Urogenital Diseases and Pregnancy Complications
Endocrine System Diseases
Gonadal Disorders
Genital Neoplasm, Female
Neoplasms, Glandular and Epithelial

Interventions

DIETARY_SUPPLEMENT: Ocoxin-Viusid

Sponsor

Catalysis SL